These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12064844)

  • 1. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
    Webster EL; Barrientos RM; Contoreggi C; Isaac MG; Ligier S; Gabry KE; Chrousos GP; McCarthy EF; Rice KC; Gold PW; Sternberg EM
    J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.
    Crofford LJ; Sano H; Karalis K; Webster EL; Goldmuntz EA; Chrousos GP; Wilder RL
    J Clin Invest; 1992 Dec; 90(6):2555-64. PubMed ID: 1281840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation.
    Misiewicz B; Poltorak M; Raybourne RB; Gomez M; Listwak S; Sternberg EM
    Exp Neurol; 1997 Aug; 146(2):305-14. PubMed ID: 9270039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.
    Webster EL; Lewis DB; Torpy DJ; Zachman EK; Rice KC; Chrousos GP
    Endocrinology; 1996 Dec; 137(12):5747-50. PubMed ID: 8940412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
    Broadbear JH; Winger G; Rivier JE; Rice KC; Woods JH
    Neuropsychopharmacology; 2004 Jun; 29(6):1112-21. PubMed ID: 14997174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2001 Aug; 44(8):1761-7. PubMed ID: 11508426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension.
    Saito-Nakaya K; Hasegawa R; Nagura Y; Ito H; Fukudo S
    Neurogastroenterol Motil; 2008 Oct; 20(10):1147-56. PubMed ID: 18761632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of corticotropin-releasing hormone receptor antagonists on the ethanol-induced increase of dynorphin A1-8 release in the rat central amygdala.
    Lam MP; Gianoulakis C
    Alcohol; 2011 Nov; 45(7):621-30. PubMed ID: 21840158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys.
    Broadbear JH; Winger G; Rice KC; Woods JH
    Psychopharmacology (Berl); 2002 Nov; 164(3):268-76. PubMed ID: 12424550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
    Deak T; Nguyen KT; Ehrlich AL; Watkins LR; Spencer RL; Maier SF; Licinio J; Wong ML; Chrousos GP; Webster E; Gold PW
    Endocrinology; 1999 Jan; 140(1):79-86. PubMed ID: 9886810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.
    Sternberg EM; Young WS; Bernardini R; Calogero AE; Chrousos GP; Gold PW; Wilder RL
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4771-5. PubMed ID: 2786636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs.
    Gabry KE; Chrousos GP; Rice KC; Mostafa RM; Sternberg E; Negrao AB; Webster EL; McCann SM; Gold PW
    Mol Psychiatry; 2002; 7(5):474-83, 433. PubMed ID: 12082565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.
    Willenberg HS; Bornstein SR; Hiroi N; Päth G; Goretzki PE; Scherbaum WA; Chrousos GP
    Mol Psychiatry; 2000 Mar; 5(2):137-41. PubMed ID: 10822340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors.
    Kohman RA; Tarr AJ; Sparkman NL; Day CE; Paquet A; Akkaraju GR; Boehm GW
    Brain Behav Immun; 2007 Aug; 21(6):824-35. PubMed ID: 17339098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of CRH receptors in urocortin-induced hyperthermia.
    Telegdy G; Adamik A
    Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of microglial cells in infrasonic noise-induced stress via upregulated expression of corticotrophin releasing hormone type 1 receptor.
    Du F; Yin L; Shi M; Cheng H; Xu X; Liu Z; Zhang G; Wu Z; Feng G; Zhao G
    Neuroscience; 2010 May; 167(3):909-19. PubMed ID: 20206673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis.
    Santora K; Rasa C; Visco D; Steinetz BG; Bagnell CA
    J Pharmacol Exp Ther; 2007 Aug; 322(2):887-93. PubMed ID: 17526806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal adenosine receptor activation inhibits inflammation and joint destruction in rat adjuvant-induced arthritis.
    Boyle DL; Moore J; Yang L; Sorkin LS; Firestein GS
    Arthritis Rheum; 2002 Nov; 46(11):3076-82. PubMed ID: 12428252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.